We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Inside AVNT's Margin Playbook: What's Driving Strength in 2026?
Read MoreHide Full Article
Key Takeaways
Avient leans on specialty materials to boost margins despite uneven 2025 volumes and demand.
AVNT targets 2026 margin gains via price, mix and productivity, not volume-driven leverage.
Defense, healthcare, telecom and chip packaging demand support AVNT's margin resilience.
Avient Corporation (AVNT - Free Report) is leaning into a specialty-materials model that is proving steadier than the typical chemical cycle. The company exited 2025 with stronger margins despite uneven volumes, and management is positioning 2026 for additional improvement driven more by mix and execution than by a broad demand surge.
That setup matters for investors because it puts the focus on what Avient can control: where it competes, how it prices and how consistently it takes costs out.
AVNT’s Mix Shift Toward Defense, Health Care and Telecom
Avient is a specialty-materials supplier focused on color, additives, inks, engineered polymers, advanced composites and performance fibers. That mix matters because these offerings tend to be more formulation and application-driven, which can support steadier pricing and better margins than commodity exposure.
The company’s end-market tilt is increasingly geared toward defense, healthcare, telecommunications and materials used in chip and wafer packaging. Those demand vectors are central to the margin-resilience narrative because they skew to higher-value, mission-critical uses where performance tends to be prioritized.
AVNT’s Specialty Engineered Materials segment is positioned as the more direct beneficiary of defense, healthcare, telecommunications and advanced materials applications, including the chip and wafer packaging exposure that has been growing at a double-digit pace, particularly in Asia.
The margin story is increasingly mix-led. Avient ended fourth-quarter 2025 with an adjusted EBITDA margin of 15.5%, up 80 basis points year over year, and delivered a full-year 2025 adjusted EBITDA margin of 16.7%, up 50 basis points. Those outcomes came despite volumes that were not uniformly supportive, underscoring the benefit of tilting toward specialty applications.
For 2026, management expects additional margin expansion driven primarily by price and mix plus productivity, rather than operating leverage. That implies earnings progression can continue even if volume improvement is modest, as long as the company keeps tightening execution and sustaining the mix shift.
Avient’s Productivity Levers That Offset Inflation
Cost execution is the second pillar of the model. Avient delivered a little over $40 million of net productivity in 2025, with about half expected to carry into 2026. The programs include ongoing sourcing work, footprint optimization and Lean Six Sigma initiatives.
That productivity is aimed at offsetting a baseline net inflation headwind of roughly $30 million in 2026. With limited operating leverage embedded in the outlook, the quality and cadence of these productivity actions become a key driver of earnings durability.
AVNT’s End-Market Signals That Matter Most
Management has described the start to 2026 as cautiously optimistic, pointing to continued strength in defense, healthcare, and telecom, along with signs of packaging improvement. Defense grew 8% in 2025 and is again expected to be strong in 2026, while demand tied to chip and wafer packaging continues to reinforce the higher-performance portfolio.
At the same time, demand has been patchy across consumer, industrial and building and construction markets. Regional trends also remain uneven, and guidance assumes only modest improvement across several challenged areas. That backdrop keeps the 2026 setup focused on modest volume improvement, with mix and productivity doing more of the heavy lifting.
AVNT’s Risks to the Resilience Thesis
The checklist starts with demand and regional variability. Macro softness, currency, trade policy, geopolitics and supply-chain shifts can keep end markets uneven and make it harder for mix benefits to fully offset slower volume recovery. Limited operating leverage raises the importance of execution on pricing and cost actions.
Defense also brings timing risk. The company has described defense as lumpy, and near-term Dyneema capacity relies on debottlenecking process improvements, with additional capacity from current investment not expected until 2028. Higher planned capital spending and paused mergers and acquisitions also limit near-term deployment flexibility. The margin narrative in 2026 ultimately comes down to whether mix shift and productivity continue to translate into steadier earnings across uneven demand conditions.
Investors may also want to compare Avient’s profile against diversified chemical peers such as Cabot Corporation (CBT - Free Report) and Tronox Holdings plc (TROX - Free Report) , which operate in the same broad industry grouping.
View the Zacks #1 Rank List
Image: Bigstock
Inside AVNT's Margin Playbook: What's Driving Strength in 2026?
Key Takeaways
Avient Corporation (AVNT - Free Report) is leaning into a specialty-materials model that is proving steadier than the typical chemical cycle. The company exited 2025 with stronger margins despite uneven volumes, and management is positioning 2026 for additional improvement driven more by mix and execution than by a broad demand surge.
That setup matters for investors because it puts the focus on what Avient can control: where it competes, how it prices and how consistently it takes costs out.
AVNT’s Mix Shift Toward Defense, Health Care and Telecom
Avient is a specialty-materials supplier focused on color, additives, inks, engineered polymers, advanced composites and performance fibers. That mix matters because these offerings tend to be more formulation and application-driven, which can support steadier pricing and better margins than commodity exposure.
The company’s end-market tilt is increasingly geared toward defense, healthcare, telecommunications and materials used in chip and wafer packaging. Those demand vectors are central to the margin-resilience narrative because they skew to higher-value, mission-critical uses where performance tends to be prioritized.
AVNT’s Specialty Engineered Materials segment is positioned as the more direct beneficiary of defense, healthcare, telecommunications and advanced materials applications, including the chip and wafer packaging exposure that has been growing at a double-digit pace, particularly in Asia.
Avient Corporation Price and Consensus
Avient Corporation price-consensus-chart | Avient Corporation Quote
AVNT’s Mix-Led Margin Playbook
The margin story is increasingly mix-led. Avient ended fourth-quarter 2025 with an adjusted EBITDA margin of 15.5%, up 80 basis points year over year, and delivered a full-year 2025 adjusted EBITDA margin of 16.7%, up 50 basis points. Those outcomes came despite volumes that were not uniformly supportive, underscoring the benefit of tilting toward specialty applications.
For 2026, management expects additional margin expansion driven primarily by price and mix plus productivity, rather than operating leverage. That implies earnings progression can continue even if volume improvement is modest, as long as the company keeps tightening execution and sustaining the mix shift.
Avient’s Productivity Levers That Offset Inflation
Cost execution is the second pillar of the model. Avient delivered a little over $40 million of net productivity in 2025, with about half expected to carry into 2026. The programs include ongoing sourcing work, footprint optimization and Lean Six Sigma initiatives.
That productivity is aimed at offsetting a baseline net inflation headwind of roughly $30 million in 2026. With limited operating leverage embedded in the outlook, the quality and cadence of these productivity actions become a key driver of earnings durability.
AVNT’s End-Market Signals That Matter Most
Management has described the start to 2026 as cautiously optimistic, pointing to continued strength in defense, healthcare, and telecom, along with signs of packaging improvement. Defense grew 8% in 2025 and is again expected to be strong in 2026, while demand tied to chip and wafer packaging continues to reinforce the higher-performance portfolio.
At the same time, demand has been patchy across consumer, industrial and building and construction markets. Regional trends also remain uneven, and guidance assumes only modest improvement across several challenged areas. That backdrop keeps the 2026 setup focused on modest volume improvement, with mix and productivity doing more of the heavy lifting.
AVNT’s Risks to the Resilience Thesis
The checklist starts with demand and regional variability. Macro softness, currency, trade policy, geopolitics and supply-chain shifts can keep end markets uneven and make it harder for mix benefits to fully offset slower volume recovery. Limited operating leverage raises the importance of execution on pricing and cost actions.
Defense also brings timing risk. The company has described defense as lumpy, and near-term Dyneema capacity relies on debottlenecking process improvements, with additional capacity from current investment not expected until 2028. Higher planned capital spending and paused mergers and acquisitions also limit near-term deployment flexibility. The margin narrative in 2026 ultimately comes down to whether mix shift and productivity continue to translate into steadier earnings across uneven demand conditions.
Investors may also want to compare Avient’s profile against diversified chemical peers such as Cabot Corporation (CBT - Free Report) and Tronox Holdings plc (TROX - Free Report) , which operate in the same broad industry grouping.
AVNT carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.